Product NDC: | 10544-374 |
Proprietary Name: | HYDROMORPHONE HYDROCHLORIDE |
Non Proprietary Name: | HYDROMORPHONE HYDROCHLORIDE |
Active Ingredient(s): | 4 mg/1 & nbsp; HYDROMORPHONE HYDROCHLORIDE |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 10544-374 |
Labeler Name: | Blenheim Pharmacal, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA078273 |
Marketing Category: | ANDA |
Start Marketing Date: | 20080529 |
Package NDC: | 10544-374-56 |
Package Description: | 56 TABLET in 1 BOTTLE (10544-374-56) |
NDC Code | 10544-374-56 |
Proprietary Name | HYDROMORPHONE HYDROCHLORIDE |
Package Description | 56 TABLET in 1 BOTTLE (10544-374-56) |
Product NDC | 10544-374 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | HYDROMORPHONE HYDROCHLORIDE |
Dosage Form Name | TABLET |
Route Name | ORAL |
Start Marketing Date | 20080529 |
Marketing Category Name | ANDA |
Labeler Name | Blenheim Pharmacal, Inc. |
Substance Name | HYDROMORPHONE HYDROCHLORIDE |
Strength Number | 4 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Full Opioid Agonists [MoA],Opioid Agonist [EPC] |